AstraZeneca says COVID-19 vaccine 76% effective in new analysis, to seek U.S. approval
Interim data published on Monday had put the vaccine’s efficacy rate at 79% but had not included more recent infections, leading to a highly unusual public rebuke from U.S health officials.
